From designing clinical trials to better understanding clinical outcomes in Lung Cancer patients
1. Our granular and quality-controlled real-world dataset can help design clinical trials that better reflect real-world scenarios.
2. The dataset can be leveraged to create synthetic control arms which can be used to evaluate the effectiveness of new lung cancer treatments.
3. Market Access and HEOR teams can gain a better understanding of the market and generate granular value dossiers.
4. Medical Affairs teams can obtain a better understanding of the clinical outcomes and real-world evidence associated with their lung cancer products.
5. Ready to explore more possibilities? ➡ CLICK HERE
* LynxCare datasets concern datasets within the LynxCare hospital network. The hospitals are the data controllers. No commitment before site approval on RWE request.
